查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888668

骨关节炎治疗市场规模、份额和趋势分析报告：按产品、应用、主要用户、地区和细分市场预测（2025-2033 年）

Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report By Product, By Application, By Primary User, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

骨关节炎治疗市场摘要

2024年全球骨关节炎治疗市场规模估计为50.2亿美元，预计2033年将达到108.9亿美元。

预计2025年至2033年，全球骨关节炎治疗市场规模将以9.0%的复合年增长率成长。 2024年，全球骨关节炎治疗市场规模估计为50.2亿美元，预计2033年将达到108.9亿美元，2025年至2033年的复合年增长率为9.0%。

根据2020年全球疾病负担（GBD）研究，全球约有5.95亿人患有骨关节炎，占全球人口的7.6%。这一数字持续成长，主要原因是人口结构变化和生活方式因素，例如人口老化和肥胖。 2024年11月发布的GBD报告指出，骨关节炎新发病例急剧增加，光是2021年就记录了约4.663亿例。由于这种疾病主要影响负重关节，尤其是膝关节，日益引起全球医疗保健系统的关注。骨关节炎盛行率的上昇在老年人族群中尤为显着。根据美国疾病管制与预防中心（CDC）2024年2月发布的数据，关节炎的发生率老龄化显着增加。 75岁及以上成年人的关节炎盛行率高达53.9%，凸显了老龄化与骨关节炎之间的密切关联。

人口老化是市场成长的主要驱动力，世界卫生组织（世卫组织）预测，到2050年，全球16%的人口将达到或超过65岁。随着老年人口的增长，尤其是在日本和欧洲等老化地区，对老龄化骨关节炎治疗的需求也不断增加。根据世卫组织2023年7月发布的报告，73%的骨关节炎患者年龄在55岁及以上，凸显了老年人族群骨关节炎的盛行率上升。为了应对这一人口结构变化，医疗保健产业正致力于开发满足老年患者独特需求的治疗方法，并考虑到许多患者存在多种合併症。截至2024年10月，医疗保健系统越来越重视老年护理，重点是开发能够改善老年骨关节炎患者活动能力和整体生活品质的治疗方法。此外，人口老化加剧，推动了对临床研究的投资，以开发创新治疗方法，如生物製药和再生药物，旨在减缓疾病进展并改善关节功能。

推动骨关节炎治疗市场发展的另一个关键因素是运动伤害和意外事故导致的关节损伤发生率不断上升。随着参与体育运动和身体活动的人数持续增加，导致关节损伤并加速骨关节炎发展的风险也随之增加。这些损伤不仅直接影响治疗方法，也促使人们更加重视关节健康管理。根据国际劳工组织（ILO）2024年的报告，全球每年约有3.95亿工人遭受非致命性工伤，其中许多会导致长期关节损伤并最终发展为骨关节炎。此外，世界卫生组织（WHO）报告称，到2024年，每年约有440万人死于伤害，其中大部分与道路交通事故有关。这种日益增强的意识促使人们更加关注预防措施，例如营养补充剂和物理疗法，以及旨在维护关节健康和促进康復的新型骨关节炎治疗方法的研发。因此，骨关节炎治疗市场正在不断开发针对骨关节炎预防和治疗的疗法，促进市场进一步成长。

目录

第一章调查方法和范围

第二章执行摘要

第三章 骨关节炎治疗市场变数、趋势与范围

  • 市场谱系展望
  • 市场动态
  • 商业环境分析
    • 产业分析—波特五力分析
    • PESTLE分析
    • 管道分析
    • 专利到期分析
    • 定价分析

第四章 骨关节炎治疗市场：依产品分類的业务分析

  • 按产品分類的市场份额（2024 年和 2033 年）
  • 按产品分類的市场规模、预测和趋势分析（2021-2033 年）
  • 黏弹性补充剂
  • 富血小板血浆（PRP）疗法
  • 骨移植替代物
  • 骨髓抽吸浓缩液（BMAC）疗法
  • 脂肪组织疗法
  • 自体软骨细胞移植术（ACI），包括MACI
  • 干细胞（其他）
  • 其他的

第五章 骨关节炎治疗市场：按应用领域分類的业务分析

  • 按应用领域分類的市场份额（2024 年和 2033 年）
  • 按应用领域分類的市场规模、预测和趋势分析（2021-2033 年）
  • 膝关节骨关节炎
  • 髋关节骨关节炎
  • 肩关节骨关节炎
  • 脊椎骨关节炎
  • 踝关节和足部骨关节炎
  • 其他的

第六章 骨关节炎治疗市场：主要使用者业务分析

  • 主要用户市场占有率（2024 年和 2033 年）
  • 主要用户市场规模、预测与趋势分析（2021-2033）
  • 骨科医生
  • 风湿症医师
  • 运动医学专家
  • 再生医学专家
  • 其他的

第七章 骨关节炎治疗市场：按地区分類的估计和趋势分析

  • 区域市场占有率分析（2024 年和 2033 年）
  • 区域市场概览
  • 市场规模及预测趋势分析（2021-2033）：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 参与企业概况
  • 企业市场分析
  • 公司分类
  • 策略规划
  • 公司简介/列表
    • Stryker
    • Zimmer Biomet Holdings, Inc.
    • Medtronic
    • Anika Therapeutics, Inc.
    • Bioventus
    • Vericel Corporation
    • Smith &Nephew
    • Fidia Farmaceutici SpA
    • Seikagaku Corporation
    • Sanofi
Product Code: GVR-4-68040-221-7

Osteoarthritis Therapeutics Market Summary

The global osteoarthritis therapeutics market size was estimated at USD 5.02 billion in 2024 and is projected to reach USD 10.89 billion by 2033, growing at a CAGR of 9.0% from 2025 to 2033. The global osteoarthritis therapeutics market size was estimated at USD 5.02 billion in 2024 and is projected to reach USD 10.89 billion by 2033, growing at a CAGR of 9.0% from 2025 to 2033.

According to the Global Burden of Disease (GBD) Study 2020, approximately 595 million people worldwide were living with osteoarthritis, representing 7.6% of the global population. This number continues to rise, primarily due to demographic shifts and lifestyle factors such as aging and obesity. The GBD report, published in November 2024, noted a sharp increase in OA cases, with approximately 466.3 million new cases recorded in 2021 alone. The condition most commonly affects weight-bearing joints, particularly the knee, making it a growing concern for healthcare systems worldwide. The rise in OA prevalence is particularly pronounced among older populations, with data from the Centers for Disease Control and Prevention (CDC) published in February 2024 indicating that arthritis rates increase substantially with age. In adults aged 75 and older, the prevalence of arthritis is as high as 53.9%, underscoring the strong correlation between aging and OA.

The growing geriatric population is a major driver of market growth, with the World Health Organization (WHO) projecting that by 2050, 16% of the global population is expected to be aged 65 or older. As the elderly population expands, particularly in regions such as Japan and Europe where the aging demographic is more pronounced, the demand for age-specific OA treatments is rising. According to the WHO's July 2023 report, 73% of individuals living with osteoarthritis are aged 55 or older, highlighting the increasing prevalence of OA in older age groups. This demographic shift has prompted the healthcare industry to focus on therapies that address the unique needs of elderly patients, many of whom also have multiple comorbidities. As of October 2024, healthcare systems are focusing more on geriatric care, emphasizing the development of treatments that improve mobility and overall quality of life for elderly OA patients. Moreover, the growth of the elderly population is catalyzing investments in clinical research to develop innovative therapies, such as biologics and regenerative treatments, aimed at slowing disease progression and enhancing joint function.

Another significant factor driving the osteoarthritis therapeutics market is the rising incidence of sports injuries and accident-related joint damage. As participation in sports and physical activities continues to increase, so does the risk of injuries that lead to joint damage and accelerate the onset of OA. In addition to the direct impact on treatment modalities, these injuries contribute to a growing awareness of the need for joint health management. The International Labour Organization (ILO), in its 2024 report, estimated that 395 million workers worldwide sustain non-fatal work injuries annually, many of which result in long-term joint damage and subsequent OA. Furthermore, the World Health Organization (WHO) reported in 2024 that injuries account for around 4.4 million deaths annually, with a significant portion of these fatalities linked to road accidents. This growing awareness has led to increased interest in preventative measures, such as nutritional supplements, physical therapy, and the development of novel OA treatments aimed at maintaining joint health and improving recovery outcomes. As a result, the osteoarthritis therapeutics market is experiencing an uptick in the development of therapies designed to address both the prevention and treatment of OA, further contributing to market growth.

Global Osteoarthritis Therapeutics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global osteoarthritis therapeutics market report based on product, application, primary user, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Viscosupplements
  • Platelet-Rich Plasma (PRP) Therapy
  • Bone Graft Substitutes
  • BMAC (Bone Marrow Aspirate Concentrate) Therapy
  • Adipose Tissue Therapy
  • Autologous Chondrocyte Implantation (ACI), Including MACI
  • Stem Cell (other)
  • Other (Cartilage Resurfacing Products)
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Shoulder Osteoarthritis
  • Spine Osteoarthritis
  • Ankle & Foot Osteoarthritis
  • Other
  • Primary User Outlook (Revenue, USD Million, 2021 - 2033)
  • Orthopedic Surgeons
  • Rheumatologists
  • Sports Medicine Specialists
  • Regenerative Medicine Specialists
  • Other
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Primary User
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Osteoarthritis Therapeutics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Osteoarthritis Therapeutics Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2033
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Viscosupplements
    • 4.4.1. Viscosupplements Market, 2021 - 2033 (USD Million)
  • 4.5. Platelet-Rich Plasma (PRP) Therapy
    • 4.5.1. Platelet-Rich Plasma (PRP) Therapy Market, 2021 - 2033 (USD Million)
  • 4.6. Bone Graft Substitutes
    • 4.6.1. Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • 4.7. BMAC (Bone Marrow Aspirate Concentrate) Therapy
    • 4.7.1. BMAC (Bone Marrow Aspirate Concentrate) Therapy Market, 2021 - 2033 (USD Million)
  • 4.8. Adipose Tissue Therapy
    • 4.8.1. Adipose Tissue Therapy Market, 2021 - 2033 (USD Million)
  • 4.9. Autologous Chondrocyte Implantation (ACI), Including MACI
    • 4.9.1. Autologous Chondrocyte Implantation (ACI), Including MACI Market, 2021 - 2033 (USD Million)
  • 4.10. Stem Cell (other)
    • 4.10.1. Stem Cell (other) Market, 2021 - 2033 (USD Million)
  • 4.11. Others
    • 4.11.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Osteoarthritis Therapeutics Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2033
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by application, 2021 to 2033 (USD Million)
  • 5.4. Knee Osteoarthritis
    • 5.4.1. Knee Osteoarthritis Market, 2021 - 2033 (USD Million)
  • 5.5. Hip Osteoarthritis
    • 5.5.1. Hip Osteoarthritis Market, 2021 - 2033 (USD Million)
  • 5.6. Shoulder Osteoarthritis
    • 5.6.1. Shoulder Osteoarthritis Market, 2021 - 2033 (USD Million)
  • 5.7. Spine Osteoarthritis
    • 5.7.1. Spine Osteoarthritis Market, 2021 - 2033 (USD Million)
  • 5.8. Ankle & Foot Osteoarthritis
    • 5.8.1. Ankle & Foot Osteoarthritis Market, 2021 - 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Osteoarthritis Therapeutics Market: Primary User Business Analysis

  • 6.1. Primary User Market Share, 2024 & 2033
  • 6.2. Primary User Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by primary user, 2021 to 2033 (USD Million)
  • 6.4. Orthopedic Surgeons
    • 6.4.1. Orthopedic Surgeons Market, 2021 - 2033 (USD Million)
  • 6.5. Rheumatologists
    • 6.5.1. Rheumatologists Market, 2021 - 2033 (USD Million)
  • 6.6. Sports Medicine Specialists
    • 6.6.1. Sports Medicine Specialists Market, 2021 - 2033 (USD Million)
  • 6.7. Regenerative Medicine Specialists
    • 6.7.1. Regenerative Medicine Specialists Market, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Osteoarthritis Therapeutics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America Osteoarthritis Therapeutics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Application Disease Prevalence
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Framework
      • 7.4.2.5. U.S. Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Application Disease Prevalence
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Framework
      • 7.4.3.5. U.S. Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Application Disease Prevalence
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Framework
      • 7.4.4.5. Mexico Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Application Disease Prevalence
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Framework
      • 7.5.2.5. Uk Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Application Disease Prevalence
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Framework
      • 7.5.3.5. Germany Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Application Disease Prevalence
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Framework
      • 7.5.4.5. France Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Application Disease Prevalence
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Reimbursement Framework
      • 7.5.5.5. Italy Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Application Disease Prevalence
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Reimbursement Framework
      • 7.5.6.5. Spain Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Application Disease Prevalence
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement Framework
      • 7.5.7.5. Denmark Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Application Disease Prevalence
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement Framework
      • 7.5.8.5. Sweden Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Application Disease Prevalence
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement Framework
      • 7.5.9.5. Norway Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Application Disease Prevalence
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Framework
      • 7.6.2.5. Japan Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Application Disease Prevalence
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Framework
      • 7.6.3.5. China Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Application Disease Prevalence
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Framework
      • 7.6.4.5. India Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Application Disease Prevalence
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Framework
      • 7.6.5.5. Australia Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Application Disease Prevalence
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement Framework
      • 7.6.6.5. South Korea Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Application Disease Prevalence
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement Framework
      • 7.6.7.5. Thailand Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Application Disease Prevalence
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Framework
      • 7.7.2.5. Japan Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Application Disease Prevalence
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Framework
      • 7.7.3.5. China Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Application Disease Prevalence
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Framework
      • 7.8.2.5. South Africa Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Application Disease Prevalence
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Framework
      • 7.8.3.5. Saudi Arabia Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Application Disease Prevalence
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Framework
      • 7.8.4.5. UAE Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Application Disease Prevalence
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Framework
      • 7.8.5.5. Kuwait Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Stryker
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Zimmer Biomet Holdings, Inc.
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Medtronic
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Anika Therapeutics, Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Bioventus
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Vericel Corporation
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Smith & Nephew
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Fidia Farmaceutici S.p.A.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Seikagaku Corporation
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Sanofi
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global osteoarthritis therapeutics market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 5 Global osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 6 Global osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 7 North America osteoarthritis therapeutics market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 9 North America osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 10 North America osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 11 U.S. osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 12 U.S. osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 13 U.S. osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 14 Canada osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 15 Canada osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 16 Canada osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 17 Mexico osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 18 Mexico osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 19 Mexico osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 20 Europe osteoarthritis therapeutics market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 22 Europe osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 23 Europe osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 24 UK osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 25 UK osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 26 UK osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 27 Germany osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 28 Germany osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 29 Germany osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 30 France osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 31 France osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 32 France osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 33 Italy osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 34 Italy osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 35 Italy osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 36 Spain osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 37 Spain osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 38 Spain osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 39 Norway osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 40 Norway osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 41 Norway osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 42 Denmark osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 43 Denmark osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 44 Denmark osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 45 Sweden osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 46 Sweden osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 47 Sweden osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific osteoarthritis therapeutics market, by country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 52 Japan osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 53 Japan osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 54 Japan osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 55 China osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 56 China osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 57 China osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 58 India osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 59 India osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 60 India osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 61 Australia osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 62 Australia osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 63 Australia osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 64 South Korea osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 65 South Korea osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 66 South Korea osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 67 Thailand osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 68 Thailand osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 69 Thailand osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 70 Latin America osteoarthritis therapeutics market, by country, 2021 - 2033 (USD Million)
  • Table 71 Latin America osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 72 Latin America osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 73 Latin America osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 74 Brazil osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 75 Brazil osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 76 Brazil osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 77 Argentina osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 78 Argentina osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 79 Argentina osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa Osteoarthritis therapeutics market, by country, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 84 South Africa osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 85 South Africa osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 86 South Africa osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 90 UAE osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 91 UAE osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 92 UAE osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 93 Kuwait osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 94 Kuwait osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 95 Kuwait osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Osteoarthritis therapeutics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Osteoarthritis therapeutics market dynamics
  • Fig. 12 Osteoarthritis therapeutics market: Porter's five forces analysis
  • Fig. 13 Osteoarthritis therapeutics market: PESTLE analysis
  • Fig. 14 Product market, 2021 - 2033 (USD Million)
  • Fig. 15 Viscosupplements market, 2021 - 2033 (USD Million)
  • Fig. 16 Platelet-Rich Plasma (PRP) Therapy market, 2021 - 2033 (USD Million)
  • Fig. 17 Bone Graft Substitutes market, 2021 - 2033 (USD Million)
  • Fig. 18 BMAC (Bone Marrow Aspirate Concentrate) Therapy market, 2021 - 2033 (USD Million)
  • Fig. 19 Adipose Tissue Therapy market, 2021 - 2033 (USD Million)
  • Fig. 20 Autologous Chondrocyte Implantation (ACI), Including MACI market, 2021 - 2033 (USD Million)
  • Fig. 21 Stem Cell (other) Substitutes market, 2021 - 2033 (USD Million)
  • Fig. 22 Others market, 2021 - 2033 (USD Million)
  • Fig. 23 Application market, 2021 - 2033 (USD Million)
  • Fig. 24 Knee Osteoarthritis market, 2021 - 2033 (USD Million)
  • Fig. 25 Hip Osteoarthritis market, 2021 - 2033 (USD Million)
  • Fig. 26 Shoulder Osteoarthritis market, 2021 - 2033 (USD Million)
  • Fig. 27 Spine Osteoarthritis market, 2021 - 2033 (USD Million)
  • Fig. 28 Ankle & Foot Osteoarthritis market, 2021 - 2033 (USD Million)
  • Fig. 29 Others market, 2021 - 2033 (USD Million)
  • Fig. 30 Primary User market, 2021 - 2033 (USD Million)
  • Fig. 31 Orthopedic Surgeons market, 2021 - 2033 (USD Million)
  • Fig. 32 Rheumatologists market, 2021 - 2033 (USD Million)
  • Fig. 33 Sports Medicine Specialists market, 2021 - 2033 (USD Million)
  • Fig. 34 Regenerative Medicine Specialists market, 2021 - 2033 (USD Million)
  • Fig. 35 Others market, 2021 - 2033 (USD Million)
  • Fig. 36 Osteoarthritis therapeutics market revenue, by region
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. country dynamics
  • Fig. 40 U.S. osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 41 Canada country dynamics
  • Fig. 42 Canada osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 43 Mexico country dynamics
  • Fig. 44 Mexico osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 45 Europe osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 46 UK country dynamics
  • Fig. 47 UK osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 48 Germany country dynamics
  • Fig. 49 Germany osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 50 France country dynamics
  • Fig. 51 France osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 52 Italy country dynamics
  • Fig. 53 Italy osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 54 Spain country dynamics
  • Fig. 55 Spain osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 56 Norway country dynamics
  • Fig. 57 Norway osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 58 Sweden country dynamics
  • Fig. 59 Sweden osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 60 Denmark country dynamics
  • Fig. 61 Denmark osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 62 Asia Pacific osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 63 Japan country dynamics
  • Fig. 64 Japan osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 65 China country dynamics
  • Fig. 66 China osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 67 India country dynamics
  • Fig. 68 India osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 69 Australia country dynamics
  • Fig. 70 Australia osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 71 South Korea country dynamics
  • Fig. 72 South Korea osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 73 Thailand country dynamics
  • Fig. 74 Thailand osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 75 Latin America osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 76 Brazil country dynamics
  • Fig. 77 Brazil osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 78 Argentina country dynamics
  • Fig. 79 Argentina osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 80 MEA osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 81 South Africa country dynamics
  • Fig. 82 South Africa osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 83 Saudi Arabia country dynamics
  • Fig. 84 Saudi Arabia osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 85 UAE country dynamics
  • Fig. 86 UAE osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 87 Kuwait country dynamics
  • Fig. 88 Kuwait osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 89 Company categorization
  • Fig. 90 Company market position analysis
  • Fig. 91 Strategic framework